GMC: 3195066


Special Interests: Adult Congenital Surgery

Mr Tsui graduated from the University of Cambridge and underwent cardiothoracic surgical training in Cambridge, Oxford and Duke University Medical School, USA. He was appointed Consultant Cardiothoracic Surgeon at Papworth Hospital in 1998 where he is the Director of Transplantation & Mechanical Circulatory Support. His clinical interests focus on surgical device therapies for end-stage heart and lung failure including extra-corporeal membrane oxygenation (ECMO), ventricular assist device (VAD), and total artificial heart (TAH). Other aspects of his clinical practice include pulmonary endarterectomy (PTE) for chronic thrombo-embolic pulmonary hypertension and trans-catheter aortic valve interventions (TAVI). His research interests include donor optimisation and ex-vivo donor organ perfusion.

He is Chairman of the Cardiothoracic Advisory Group at NHS Blood & Transplant (NHSBT), UK and Chairman of the Specialty Training Committee for Cardiothoracic Surgery in Health Education East of England.

Training Attended
No further information available
Qualifications & Accreditations

BA 1985 University of Cambridge

MA 1987 University of Cambridge

MB BCh 1988 University of Cambridge

F.R.C.S.(Eng.) 1992 Royal College of Surgeons of England

MD 1995 University of Cambridge

F.R.C.S. (C-Th) 1997 Inter-collegiate Specialty Board in Cardiothoracic Surgery

Additional Information
No further information available

Risk-adjusted in-hospital survival rate

This graph shows the “in hospital” survival rate of patients who are operated on by the individual surgeon/unit you have selected. “In hospital” means time the patient is in the hospital where they have had their operation. It does not include any time that patients may have spent in other hospitals, either before or after their heart operation.

The data has been through a complex methodology, including the variations in patient risk factors in order to give you a comparative base from which to work from. This means that the survival rates take into account the type and risk of patients being operated on for each surgeon/unit. This is known as risk adjusted survival.

The vertical axis shows the GMC number of the surgeon or the Hospital identifier. In brackets is the total number of patients operated on by the surgeon/unit and the percentage of patients for whom the survival is known. The horizontal axis is the percentage survival. The dashed vertical line shows the risk adjusted survival rate for the UK as a whole. The solid black horizontal line represents the surgeon/unit. What is important here is that the horizontal line crosses the vertical dashed line. If this occurs, it means that the surgeon/unit are within the expected outcomes given the case-mix and risk factors of the patients they operate on.

The icons that sit on the horizontal line should give you more information about your surgeon/team.

For example

The open square is the survival rate with no risk adjustments:
The X is the predicted survival with adjustments
The solid dot is the survival probability after the methodology has been applied.

  • If the solid dot is red it means survival is worse than expected
  • If the solid dot is black it means that it is within limits
  • If the solid dot is green it means that there is significantly higher survival than expected

There is a lot of information on these plots, but the takeaway message is that if the solid black line crosses the dashed vertical line then the survival rate for the surgeon/unit is within expectations and that there is no reason for any concern.

A more detailed explanation about these graphs and methodology can be found here: Graph Explanations

Data for period April 2016 – March 2019.
Risk Adjusted In-Hospital Survival Rate